Wilson H. Miller

机构：Boone Hospital Center, Jewish General Hospital · ORCID：0000-0002-7408-1574

发表论文 625 篇 · 总被引 46894 次 · h-index 82

代表论文

KEYMAKER-U03 substudy 03B: Novel investigative regimens for previously treated advanced clear cell renal cell carcinoma (ccRCC). (2026 · Journal of Clinical Oncology · 被引 2)
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma (2026 · Future Oncology · 被引 1)
A mixed inflammatory peripheral signature defines clinical outcomes in a phase II trial combining pembrolizumab with paclitaxel and carboplatin in melanoma (2026 · OncoImmunology · 被引 1)
Franchise Law (2026 · SMU Annual Texas Survey)
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma (2026 · Figshare)
Plain language summary of the LOGIC 2 study: Encorafenib, binimetinib, plus a third drug for people with BRAF V600-mutant melanoma (2026 · Figshare)